Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Cell Rep ; 35(12): 109275, 2021 06 22.
Artigo em Inglês | MEDLINE | ID: mdl-34161774

RESUMO

The mitochondrial calcium uniporter (MCU), the highly selective channel responsible for mitochondrial Ca2+ entry, plays important roles in physiology and pathology. However, only few pharmacological compounds directly and selectively modulate its activity. Here, we perform high-throughput screening on a US Food and Drug Administration (FDA)-approved drug library comprising 1,600 compounds to identify molecules modulating mitochondrial Ca2+ uptake. We find amorolfine and benzethonium to be positive and negative MCU modulators, respectively. In agreement with the positive effect of MCU in muscle trophism, amorolfine increases muscle size, and MCU silencing is sufficient to blunt amorolfine-induced hypertrophy. Conversely, in the triple-negative breast cancer cell line MDA-MB-231, benzethonium delays cell growth and migration in an MCU-dependent manner and protects from ceramide-induced apoptosis, in line with the role of mitochondrial Ca2+ uptake in cancer progression. Overall, we identify amorolfine and benzethonium as effective MCU-targeting drugs applicable to a wide array of experimental and disease conditions.


Assuntos
Canais de Cálcio/metabolismo , United States Food and Drug Administration , Animais , Apoptose/efeitos dos fármacos , Benzetônio/farmacologia , Neoplasias da Mama/patologia , Cálcio/metabolismo , Linhagem Celular Tumoral , Movimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Citoproteção/efeitos dos fármacos , Cloridrato de Duloxetina/farmacologia , Metabolismo Energético/efeitos dos fármacos , Feminino , Ensaios de Triagem em Larga Escala , Homeostase/efeitos dos fármacos , Humanos , Hipertrofia , Camundongos , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Morfolinas/farmacologia , Fibras Musculares Esqueléticas/efeitos dos fármacos , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/patologia , Consumo de Oxigênio/efeitos dos fármacos , Espécies Reativas de Oxigênio/metabolismo , Reprodutibilidade dos Testes , Estados Unidos
2.
Asian Pac J Cancer Prev ; 21(6): 1709-1716, 2020 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-32592368

RESUMO

Combination therapy has been the trendy of care, particularly in cancer remedy, since it is a rational approach to increase response and tolerability and to diminish resistance. Hence, there is a growing interest in combining anticancer drugs to maximizing efficacy with minimum systemic toxicity through the delivery of lower drug doses. Therefore, in the present study, the value of combination between benzethonium chloride (benzo) and endoxan (endo) as anti-tumor drug sensitization of hepatocellular carcinoma HCC treatment were detected both in vitro and in vivo. Crystal violet test was performed to detect the proliferation of HepG2 cells treated with benzo or/and endo. In addition, the HCC rat model was established by diethylnitrosamine (DEN) administration. The antitumor effect was enhanced with the combined treatment of the two drugs, particularly in the group with benzo and endo. The results confirmed that the HCC condition was developed in response to lower expressions of caspase 3 and P53 which, in turn, was due to the overexpression of Bcl-2, and downregulation of cytochrome C. The treatment with benzo combined with endo caused significant activation of caspase-3 mediated apoptotic signals that could be responsible for its anti-HCC potential. Meantime, benzo combined with endo treatments could reduce the hepatocellular carcinogenesis by reducing the expression of MMP-9. Therefore, benzo and endo treatments may be a hopeful therapeutic drug for HCC. Also, more studies are recommended to feat the idea of this research for medical use.
.


Assuntos
Proteínas Reguladoras de Apoptose/metabolismo , Apoptose , Benzetônio/farmacologia , Carcinoma Hepatocelular/patologia , Ciclofosfamida/farmacologia , Sinergismo Farmacológico , Neoplasias Hepáticas/patologia , Animais , Anti-Infecciosos Locais/farmacologia , Antineoplásicos Alquilantes/farmacologia , Carcinoma Hepatocelular/tratamento farmacológico , Carcinoma Hepatocelular/metabolismo , Proliferação de Células , Quimioterapia Combinada , Humanos , Neoplasias Hepáticas/tratamento farmacológico , Neoplasias Hepáticas/metabolismo , Masculino , Ratos , Células Tumorais Cultivadas , Ensaios Antitumorais Modelo de Xenoenxerto
4.
Toxicol Appl Pharmacol ; 267(2): 155-66, 2013 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-23313619

RESUMO

Tetra-n-octylammonium bromide and benzethonium chloride are synthetic quaternary ammonium salts that are widely used in hospitals and industries for the disinfection and surface treatment and as the preservative agent. Recently, the activities of HERG channel inhibition by these compounds have been found to have potential risks to induce the long QT syndrome and cardiac arrhythmia, although the mechanism of action is still elusive. This study was conducted to investigate the mechanism of HERG channel inhibition by these compounds by using whole-cell patch clamp experiments in a CHO cell line stably expressing HERG channels. Tetra-n-octylammonium bromide and benzethonium chloride exhibited concentration-dependent inhibitions of HERG channel currents with IC(50) values of 4nM and 17nM, respectively, which were also voltage-dependent and use-dependent. Both compounds shifted the channel activation I-V curves in a hyperpolarized direction for 10-15mV and accelerated channel activation and inactivation processes by 2-fold. In addition, tetra-n-octylammonium bromide shifted the inactivation I-V curve in a hyperpolarized direction for 24.4mV and slowed the rate of channel deactivation by 2-fold, whereas benzethonium chloride did not. The results indicate that tetra-n-octylammonium bromide and benzethonium chloride are open-channel blockers that inhibit HERG channels in the voltage-dependent, use-dependent and state-dependent manners.


Assuntos
Benzetônio/farmacologia , Canais de Potássio Éter-A-Go-Go/antagonistas & inibidores , Bloqueadores dos Canais de Potássio/farmacologia , Compostos de Amônio Quaternário/farmacologia , Animais , Células CHO , Cricetinae , Cricetulus , Relação Dose-Resposta a Droga
5.
PLoS One ; 7(7): e40005, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22808084

RESUMO

ABCB6 is a member of the adenosine triphosphate (ATP)-binding cassette family of transporter proteins that is increasingly recognized as a relevant physiological and therapeutic target. Evaluation of modulators of ABCB6 activity would pave the way toward a more complete understanding of the significance of this transport process in tumor cell growth, proliferation and therapy-related drug resistance. In addition, this effort would improve our understanding of the function of ABCB6 in normal physiology with respect to heme biosynthesis, and cellular adaptation to metabolic demand and stress responses. To search for modulators of ABCB6, we developed a novel cell-based approach that, in combination with flow cytometric high-throughput screening (HTS), can be used to identify functional modulators of ABCB6. Accumulation of protoporphyrin, a fluorescent molecule, in wild-type ABCB6 expressing K562 cells, forms the basis of the HTS assay. Screening the Prestwick Chemical Library employing the HTS assay identified four compounds, benzethonium chloride, verteporfin, tomatine hydrochloride and piperlongumine, that reduced ABCB6 mediated cellular porphyrin levels. Validation of the identified compounds employing the hemin-agarose affinity chromatography and mitochondrial transport assays demonstrated that three out of the four compounds were capable of inhibiting ABCB6 mediated hemin transport into isolated mitochondria. However, only verteporfin and tomatine hydrochloride inhibited ABCB6's ability to compete with hemin as an ABCB6 substrate. This assay is therefore sensitive, robust, and suitable for automation in a high-throughput environment as demonstrated by our identification of selective functional modulators of ABCB6. Application of this assay to other libraries of synthetic compounds and natural products is expected to identify novel modulators of ABCB6 activity.


Assuntos
Transportadores de Cassetes de Ligação de ATP/metabolismo , Citometria de Fluxo/métodos , Ensaios de Triagem em Larga Escala , Mitocôndrias/efeitos dos fármacos , Porfirinas/farmacologia , Protoporfirinas/metabolismo , Tomatina/farmacologia , Transportadores de Cassetes de Ligação de ATP/antagonistas & inibidores , Benzetônio/farmacologia , Transporte Biológico/efeitos dos fármacos , Cromatografia de Afinidade , Dioxolanos/farmacologia , Hemina/análogos & derivados , Hemina/antagonistas & inibidores , Hemina/metabolismo , Humanos , Células K562 , Mitocôndrias/metabolismo , Modelos Moleculares , Protoporfirinas/antagonistas & inibidores , Sefarose/análogos & derivados , Bibliotecas de Moléculas Pequenas , Verteporfina
6.
Stem Cell Rev Rep ; 8(1): 116-27, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21617963

RESUMO

A potential application of embryonic and inducible pluripotent stem cells for the therapy of degenerative diseases involves pure somatic cells, free of tumorigenic undifferentiated embryonic and inducible pluripotent stem cells. In complex collections of chemicals with pharmacological potential we expect to find molecules able to induce specific pluripotent stem cell death, which could be used in some cell therapy settings to eliminate undifferentiated cells. Therefore, we have screened a chemical library of 1120 small chemicals to identify compounds that induce specifically apoptotic cell death in undifferentiated mouse embryonic stem cells (ESCs). Interestingly, three compounds currently used as clinically approved drugs, nortriptyline, benzethonium chloride and methylbenzethonium chloride, induced differential effects in cell viability in ESCs versus mouse embryonic fibroblasts (MEFs). Nortriptyline induced apoptotic cell death in MEFs but not in ESCs, whereas benzethonium and methylbenzethonium chloride showed the opposite effect. Nortriptyline, a tricyclic antidepressant, has also been described as a potent inhibitor of mitochondrial permeability transition, one of two major mechanisms involved in mitochondrial membrane permeabilization during apoptosis. Benzethonium chloride and methylbenzethonium chloride are quaternary ammonium salts used as antimicrobial agents with broad spectrum and have also been described as anticancer agents. A similar effect of benzethonium chloride was observed in human induced pluripotent stem cells (hiPSCs) when compared to both primary human skin fibroblasts and an established human fibroblast cell line. Human fibroblasts and hiPSCs were similarly resistant to nortriptyline, although with a different behavior. Our results indicate differential sensitivity of ESCs, hiPSCs and fibroblasts to certain chemical compounds, which might have important applications in the stem cell-based therapy by eliminating undifferentiated pluripotent stem cells from stem cell-derived somatic cells to prevent tumor formation after transplantation for therapy of degenerative diseases.


Assuntos
Apoptose/efeitos dos fármacos , Citotoxinas/farmacologia , Células-Tronco Pluripotentes/fisiologia , Animais , Benzetônio/análogos & derivados , Benzetônio/farmacologia , Caspase 3/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Fibroblastos/fisiologia , Humanos , Dose Letal Mediana , Camundongos , Nortriptilina/farmacologia , Células-Tronco Pluripotentes/efeitos dos fármacos , Células-Tronco Pluripotentes/metabolismo , Bibliotecas de Moléculas Pequenas
7.
Bioorg Med Chem Lett ; 18(24): 6451-3, 2008 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-18993063

RESUMO

C4-Fluorinated analogues of solamin, an antitumor acetogenin, were synthesized and investigated for their antitumor activities against 39 tumor cell lines. C4-Fluorinated solamins showed more potent growth inhibitory activity against cancer cell lines than solamin.


Assuntos
Antineoplásicos/síntese química , Benzetônio/síntese química , Acetogeninas/química , Antineoplásicos/farmacologia , Benzetônio/farmacologia , Linhagem Celular Tumoral , Química Farmacêutica/métodos , Desenho de Fármacos , Ensaios de Seleção de Medicamentos Antitumorais , Humanos , Concentração Inibidora 50 , Modelos Químicos , Estereoisomerismo , Relação Estrutura-Atividade
8.
Clin Cancer Res ; 12(18): 5557-69, 2006 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-17000693

RESUMO

PURPOSE: This study aims to identify a novel therapeutic agent for head and neck cancer and to evaluate its antitumor efficacy. EXPERIMENTAL DESIGN: A cell-based and phenotype-driven high-throughput screening of approximately 2,400 biologically active or clinically used compounds was done using a tetrazolium-based assay on FaDu (hypopharyngeal squamous cancer) and NIH 3T3 (untransformed mouse embryonic fibroblast) cells, with secondary screening done on C666-1 (nasopharyngeal cancer) and GM05757 (primary normal human fibroblast) lines. The "hit" compound was assayed for efficacy in combination with standard therapeutics on a panel of human cancer cell lines. Furthermore, its mode of action (using transmission electron microscopy and flow cytometry) and its in vivo efficacy (using xenograft models) were evaluated. RESULTS: Benzethonium chloride was identified as a novel cancer-specific compound. For benzethonium (48-hour incubation), the dose required to reduce cell viability by 50% was 3.8 micromol/L in FaDu, 42.2 micromol/L in NIH 3T3, 5.3 micromol/L in C666-1, and 17.0 micromol/L in GM05757. In vitro, this compound did not interfere with the effects of cisplatin, 5-fluorouracil, or gamma-irradiation. Benzethonium chloride induced apoptosis and activated caspases after 12 hours. Loss of mitochondrial membrane potential (DeltaPsiM) preceded cytosolic Ca2+ increase and cell death. In vivo, benzethonium chloride ablated the tumor-forming ability of FaDu cells, delayed the growth of xenograft tumors, and combined additively with local tumor radiation therapy. Evaluation of benzethonium chloride on the National Cancer Institute/NIH Developmental Therapeutics Program 60 human cancer cell lines revealed broad-range antitumor activity. CONCLUSIONS: This high-throughput screening identified a novel antimicrobial compound with significant broad-spectrum anticancer activity.


Assuntos
Antineoplásicos/isolamento & purificação , Benzetônio/isolamento & purificação , Ensaios de Seleção de Medicamentos Antitumorais/métodos , Análise Serial de Tecidos/métodos , Animais , Antineoplásicos/farmacologia , Antineoplásicos/uso terapêutico , Apoptose/efeitos dos fármacos , Benzetônio/farmacologia , Benzetônio/uso terapêutico , Cálcio/metabolismo , Caspases/metabolismo , Proliferação de Células/efeitos dos fármacos , Proliferação de Células/efeitos da radiação , Sobrevivência Celular/efeitos dos fármacos , Quimioterapia Combinada , Feminino , Neoplasias de Cabeça e Pescoço/tratamento farmacológico , Neoplasias de Cabeça e Pescoço/radioterapia , Humanos , Potenciais da Membrana/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos BALB C , Camundongos SCID , Membranas Mitocondriais/efeitos dos fármacos , Modelos Biológicos , Células NIH 3T3 , Neoplasias/tratamento farmacológico , Neoplasias/radioterapia , Radiossensibilizantes/farmacologia , Radiossensibilizantes/uso terapêutico , Células Tumorais Cultivadas , Ensaios Antitumorais Modelo de Xenoenxerto/métodos
9.
J Org Chem ; 69(10): 3368-74, 2004 May 14.
Artigo em Inglês | MEDLINE | ID: mdl-15132544

RESUMO

An efficient total synthesis of cis-solamin (1) has been achieved in 21% overall yield and with a longest linear sequence of just 11 steps from aldehyde 8. A key feature of the approach was the use of asymmetric permanganate-promoted oxidative cyclization to introduce four of the five required stereocenters in a single step. The use of robust and chemoselective methodology meant that the use of protecting groups could be avoided during the assembly of cis-solamin (1) from the three fragments 23, 6, and 4. The methodology was also applied to the synthesis of three further cis-solamin isomers 2, ent-1, and ent-2. Cytotoxicity and hemolytic properties of cis-solamin isomers and synthetic intermediates are reported.


Assuntos
Benzetônio/análogos & derivados , Animais , Benzetônio/síntese química , Benzetônio/farmacologia , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Ciclização , Compostos de Epóxi/síntese química , Concentração Inibidora 50 , Isomerismo , Estrutura Molecular , Relação Estrutura-Atividade
10.
Am J Gastroenterol ; 96(6): 1803-6, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11419833

RESUMO

OBJECTIVES: The effectiveness of manual cleaning and disinfection of gastroendoscopes with 3% glutaraldehyde in decreasing the risk of transmission of hepatitis C virus (HCV) was examined. METHODS: Gastroendoscopes used for treatment of endoscopic esophageal variceal ligation in patients with HCV infection were manually cleaned and disinfected with 3% glutaraldehyde (n = 25), 2% glutaraldehyde (n = 17), or 0.1% benzethonium chloride (n = 25). Samples were obtained by pouring 20 ml of 0.9% NaCl solution into the biopsy-suction channel of the scope before and after cleaning and disinfection. HCV was detected with the polymerase chain reaction. RESULTS: Of the 25 scopes in 3% glutaraldehyde group, nine (36%) were positive for HCV before cleaning and disinfection, but all became negative after cleaning and disinfection; the difference was statistically significant (p < 0.01). In contrast, in 2% glutaraldehyde group and in the routine cleaning group, there were no significant differences in the number of positive samples between before and after cleaning and disinfection. CONCLUSION: Manual cleaning and disinfection of gastroscopes with 3% glutaraldehyde is useful for decreasing the risk of transmission of HCV among patients.


Assuntos
Desinfetantes/farmacologia , Gastroscópios/virologia , Glutaral/farmacologia , Hepatite C/transmissão , Benzetônio/farmacologia , Varizes Esofágicas e Gástricas/virologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
11.
Anesthesiology ; 89(5): 1218-27, 1998 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9822011

RESUMO

BACKGROUND: Various anesthetics have been suggested to interfere with the immune system. The ability of leukocytes to express surface receptors and mediators is fundamental to a successful host defense. Therefore, the effects of intravenous anesthetics on cytokine release by leukocytes and expression of surface molecules known to modulate this response were determined. METHODS: Concentration-dependent effects of thiopentone, etomidate, propofol, ketamine, midazolam, and fentanyl on spontaneous and endotoxin (lipopolysaccharide; 1 microg/ml)-stimulated cytokine release were studied in whole blood from volunteers (n = 6) cultured for 25 h. In addition, expression of the lipopolysaccharide-recognition molecule CD14 and the major histocompatibility complex class II molecule human leukocyte locus A system-DR (HLA-DR) on monocytes were assessed using flow cytometry. RESULTS: All anesthetics studied elicited only minor effects on spontaneous cytokine release even at pharmacologic concentrations. However, expression density of CD14 was reduced in the presence of thiopentone, etomidate, and propofol, whereas HLA-DR was unaffected. Lipopolysaccharide-stimulated tumor necrosis factor response was inhibited by thiopentone (12.8% [median]; 7.6-18.8 [25-75 percentile]) of control, and ketamine (46.4% [median]; 44.4-56.4 [25-75 percentile]), at pharmacologic concentrations, whereas it was augmented even in the presence of low concentrations of propofol (172.3% [median]; 120.5-200.7 [25-75 percentile]). Ketamine additionally decreased the concentration of interleukin (IL)-1beta (14.8% [median]; 12.0-18.0 [25-75 percentile]). Release of IL-1 receptor antagonist (IL-1ra) was inhibited by thiopentone, etomidate, and propofol, whereas the same anesthetics increased IL-10 concentration simultaneously. Midazolam and fentanyl did not alter the concentrations of any cytokine. CONCLUSIONS: These results suggest a complex modulation of the cytokine response by the studied anesthetics in cultured whole blood. Although effects on spontaneous cytokine release by leukocytes were negligible, some anesthetics affected their ability to respond to lipopolysaccharide.


Assuntos
Anestésicos Intravenosos/farmacologia , Citocinas/sangue , Endotoxinas/farmacologia , Lipopolissacarídeos/farmacologia , Benzetônio/farmacologia , Citometria de Fluxo , Antígenos HLA-DR/sangue , Humanos , Concentração de Íons de Hidrogênio , Técnicas In Vitro , Receptores de Lipopolissacarídeos/sangue , Concentração Osmolar
12.
Dermatology ; 195 Suppl 2: 29-35, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9403252

RESUMO

Inactivation of a range of viruses, such as adeno-, mumps, rota-, polio- (types 1 and 3), coxsackie-, rhino-, herpes simplex, rubella, measles, influenza and human immunodeficiency viruses, by povidone-iodine (PVP-I) and other commercially available antiseptics in Japan was studied in accordance with the standardized protocol in vitro. In these experiments, antiseptics such as PVP-I solution, PVP-I gargle, PVP-I cream, chlorhexidine gluconate, alkyldiaminoethyl-glycine hydrochloride, benzalkonium chloride (BAC) and benzethonium chloride (BEC) were used. PVP-I was effective against all the virus species tested. PVP-I drug products, which were examined in these experiments, inactivated all the viruses within a short period of time. Rubella, measles, mumps viruses and HIV were sensitive to all of the antiseptics, and rotavirus was inactivated by BAC and BEC, while adeno-, polio- and rhinoviruses did not respond to the other antiseptics. PVP-I had a wider virucidal spectrum, covering both enveloped and nonenveloped viruses, than the other commercially available antiseptics.


Assuntos
Anti-Infecciosos Locais/farmacologia , Antivirais/farmacologia , Vírus de DNA/efeitos dos fármacos , Iodóforos/farmacologia , Povidona-Iodo/farmacologia , Vírus de RNA/efeitos dos fármacos , Adenoviridae/efeitos dos fármacos , Anti-Infecciosos Locais/administração & dosagem , Antivirais/administração & dosagem , Compostos de Benzalcônio/administração & dosagem , Compostos de Benzalcônio/farmacologia , Benzetônio/administração & dosagem , Benzetônio/farmacologia , Clorexidina/administração & dosagem , Clorexidina/análogos & derivados , Clorexidina/farmacologia , Enterovirus/efeitos dos fármacos , Glicina/administração & dosagem , Glicina/farmacologia , HIV/efeitos dos fármacos , Humanos , Iodóforos/administração & dosagem , Vírus do Sarampo/efeitos dos fármacos , Antissépticos Bucais , Vírus da Caxumba/efeitos dos fármacos , Pomadas , Orthomyxoviridae/efeitos dos fármacos , Poliovirus/efeitos dos fármacos , Povidona-Iodo/administração & dosagem , Rhinovirus/efeitos dos fármacos , Rotavirus/efeitos dos fármacos , Vírus da Rubéola/efeitos dos fármacos , Simplexvirus/efeitos dos fármacos
14.
Peptides ; 17(2): 313-20, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8801539

RESUMO

Benzethonium chloride (Bztc) is the first totally nonpeptide ligand for an insect, indeed an invertebrate, peptide receptor. Bztc mimics the inhibitory physiological activity of the myosuppressins, a subfamily of the FLRFamides, in three different insect bioassay systems. The inhibitory action of leucomyosuppressin and the nonpeptide Bztc in both the cockroach hindgut and the mealworm neuromuscular junction can be blocked by the lipoxygenase inhibitor, nordihydroguaiaretic acid, providing evidence for similar modes of action. Lipoxygenase metabolites of arachidonic acid may mediate inhibition of neuromuscular transmission by these two factors. In addition, Bztc competitively displaces a radiolabeled myosuppressin analogue from high- and low-affinity receptors of the locust oviduct. Thus, the nonpeptide interacts with both binding and activating regions of myosuppressin receptors. Molecular dynamics experiments in which selected functional groups of Bztc were fit onto corresponding functional groups of low-energy myosuppressin pentapeptide structures indicate how Bztc may mimic the myosuppressins at a molecular level. The discovery of Bztc as a nonpeptidal peptidomimetic analogue provides an opportunity to develop new pest management strategies by targeting an insect's own peptide receptor.


Assuntos
Benzetônio/farmacologia , Hormônios de Inseto/farmacologia , Junção Neuromuscular/efeitos dos fármacos , Neuropeptídeos/farmacologia , Oligopeptídeos/agonistas , Sequência de Aminoácidos , Animais , Ácido Araquidônico/farmacologia , Baratas , Indometacina/farmacologia , Hormônios de Inseto/agonistas , Masoprocol/farmacologia , Modelos Moleculares , Mimetismo Molecular , Dados de Sequência Molecular , Neuropeptídeos/agonistas , Conformação Proteica
15.
Contraception ; 20(5): 489-95, 1979 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-393457

RESUMO

326 healthy couples were selected to enter the trial of a new intravaginal contraceptive called the TA-RO CAP. The trial lasted three years. Clinical and laboratory examinations were performed periodically to determine the long-term effectiveness, tolerability and acceptance. Statistical evaluation of results was performed by life-table analysis.


PIP: A new vaginal cap (TA-RO-CAP) composed of multiple spermicidal contraceptive agents was tested clinically by 326 couples to evaluate the long-term effectiveness, tolerability, and acceptance of this new contraceptive method. The CAP, in the form of a watch-glass, designed for intravaginal use, contained: benzethoniom chloride, 4.5 mg; nonoxynol 9, 39 mg; polyethylene-glycol 600, 78.6 mg; polyethylene-glycol-1500, 64.4 mg; dipropylene-glycol, 11.2 mg; mannitol, 100.8 mg; starch, 40 mg; and perfume, 1.5 mg. 230 couples (70.5%) completed the trial, which involved 4582 months of use, with each couple averaging 14 months. The total pregnancies which occurred was 26; these were divided among 3 centers. 2 of 26 pregnancies were shown to result from improper usage (insertion after coitus). 29 couples discontinued use for personal reasons, and none had any side effects during the trial. 16 of these discontinuations were provoked by the male partner. 5.5% of couples experienced mild side effects, such as redness or irritation, but only 1 case discontinued because of them. None of the women showed neoplastic degeneration of the portion or in the vagina after colposcopy and vaginal oncological cytology examinations. The statistical evaluation of this 3-year long trial is presented in a life-table.


Assuntos
Benzetônio/farmacologia , Polietilenoglicóis/farmacologia , Compostos de Amônio Quaternário/farmacologia , Espermicidas/farmacologia , Vagina , Cremes, Espumas e Géis Vaginais/farmacologia , Análise Atuarial , Adulto , Ensaios Clínicos como Assunto , Combinação de Medicamentos , Feminino , Humanos , Masculino , Nonoxinol , Gravidez , Fatores de Tempo
17.
J Invest Dermatol ; 69(1): 136-45, 1977 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-874343

RESUMO

New, reliable, and precise methods for measuring absolute pressure sensitivity in mucous membranes and on intact skin are described. Studies were conducted to determine how local anesthetics (phenol and sodium phenolate and Benzocaine) affect tactile sensitivity thresholds in the oropharynx and on the intact skin of the volar surface of the forearms, ankles, knees, elbows, and dorsum of the hands. Gargling and expectorating a solution containing phenol had a significantly greater anesthetic effect on the mucous membranes of the oropharynx than spraying and swallowing, which, in turn, had a greater effect than drinking the solution. Compared with ethanol and petroleum jelly (Vaseline), the topical application of Benzocaine (0, .5, 1, 3, and 5% solutions in 100% ethanol) significantly increased the tactile sensory thresholds on the volar surface of the forearm. A highly significant loss of tactual sensitivity of the oropharynx was demonstrated in smokers.


Assuntos
Anestésicos Locais/farmacologia , Pele/inervação , Tato/efeitos dos fármacos , Adolescente , Adulto , Anestesiologia/instrumentação , Anestésicos Locais/administração & dosagem , Benzetônio/farmacologia , Benzocaína/farmacologia , Deglutição , Limiar Diferencial , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Mucosa Bucal/inervação , Mucosa/inervação , Vaselina/farmacologia , Faringe/fisiologia , Faringe/fisiopatologia , Fenóis/farmacologia , Pressão , Fumar/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA